PDE3B Antikörper (AA 1050-2000)
Kurzübersicht für PDE3B Antikörper (AA 1050-2000) (ABIN2747092)
Target
Alle PDE3B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1050-2000
-
Aufreinigung
- Affinity Purified
-
Immunogen
- Synthetic peptide taken within amino acid region 1050-2000 on mouse PDE3B protein. Will label all variants of PDE3B.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.7 μg/μL
-
-
-
: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).
: "Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose." in: Endocrinology, Vol. 149, Issue 2, pp. 741-8, (2008) (PubMed).
: "Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis." in: Molecular pharmacology, Vol. 67, Issue 1, pp. 263-72, (2005) (PubMed).
-
: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).
-
- PDE3B (phosphodiesterase 3B, CGMP-Inhibited (PDE3B))
-
Andere Bezeichnung
- PDE3B
-
UniProt
- Q63085
-
Pathways
- Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process
Target
-